Abstract: The present disclosure relates to the technical field of medical instruments, in particular to a bodily fluid collector and a bodily fluid collection method. The bodily fluid collector of the present disclosure comprises a collection member and a storage member having a storage chamber. Moreover, the storage chamber of the storage member may be partitioned into a first chamber for receiving a bodily fluid and a second chamber for storing a preservative product separated from each other by fitting a lower end of the collection member with the storage member, such that the isolation of the bodily fluid from the preservative product is no longer dependent on the sealing of a thin film, but only needs to engage the collection member with the storage member, and also such that the mixing of the bodily fluid with the preservative product is no longer dependent on the damage of the thin film by a blade, but only needs to separate the collection member from the storage member.

Abstract: The invention provides pantoprazole sodium composition lyophilized powder for injection, and relates to the technical field of medicines and manufacturing of the medicines. The pantoprazole sodium composition lyophilized powder for injection comprises the following raw material ingredients in parts by weight: 7.24-9.08 parts of pantoprazole sodium, 4.34-5.45 parts of chitosan nanoparticles and 85.25-89.11 parts of water for injection. The invention has the following advantages: 1) a composition comprising pantoprazole sodium and chitosan nanoparticles according to a ratio of 1:0.

Abstract: A portable air cleaner includes a host connected to a mask through a flexible pipe. The host includes a pressurizing and filtering chamber, an elementary air-storing chamber, a secondary air-storing chamber, a jet port and a valve. The pressurizing and filtering chamber includes a pump and a filtering unit placed therein. The elementary air-storing chamber includes a negative ion producer placed therein. The secondary air-storing chamber includes a pressure sensor, a temperature sensor and a temperature-changing element placed therein. The pressurizing and filtering chamber is connected to the elementary air-storing chamber through the jet port. The elementary air-storing chamber is connected to the secondary air-storing chamber through the valve.

Abstract: An ambroxol hydrochloride composition and a preparation method therefor. 0.1%-99.9% by mass of ambroxol hydrochloride and 99.9%-0.1% by mass of scopolamine serving as main ingredients and mannitol are added into water for injection; dissolve, then adjust to pH 5.0; add 0.1% of activated carbon with stirring; filter out the activated carbon, and then filter the liquid; send into a lyophilizer, cool to ?40° C., and hold the temperature for 2 hours; warm to ?5° C. to 0° C. slowly to lyophilize the liquid, heat to 35° C., and hold the temperature for 3 hours; take out of the lyophilizer to obtain a lyophilized powder injection containing ambroxol hydrochloride and scopolamine; crush the lyophilized powder injection under sterile conditions, and sieve to obtain sterile lyophilized powder containing ambroxol hydrochloride and scopolamine; and prepare various dosage forms by using the lyophilized powder as a raw material.

Abstract: A compound ambroxol hydrochloride composition and a preparation method therefor, which relate to the field of medicine. 0.1%-99.9% by mass of ambroxol hydrochloride and 99.9%-0.1% by mass of scopolamine serving as main ingredients and mannitol are added into water for injection; stir to dissolve, then adjusting to pH 5.0 by adding an NaOH solution; add 0.1% of activated carbon with stirring for 30 minutes; filter out the activated carbon, and then filtering the liquid with 0.45 ?m and 0.22 ?m microporous filter membranes; fill the filtered liquid into a large plate or a vial; send into a lyophilizer, cool to ?40° C., and hold the temperature for 2 hours; warm to ?5° C. to 0° C. slowly to lyophilize the liquid, heat to 35° C.

Abstract: A pharmaceutical composition of glutathione and acetaminophen and preparation method thereof. The active ingredients of the composition include glutathione with composition ration of 0.1%˜99.9% and acetaminophen with composition ratio of 99.9%˜0.1%. The further purpose of the invention is to prepare glutathione and acetaminophen composition (raw materials) into various pharmaceutically acceptable dosage forms, such as tablets, sustained/controlled release preparations, capsules, pills, syrups, films, granules, oral solutions, oral suspensions, oral emulsions and oral powders. The beneficial effects of the invention is reflected in that glutathione and acetaminophen combination can effectively prevent the liver cell damage and necrosis caused by acetaminophen overdose and is strongly in favor of cancer pain relief and chemotherapy.

Abstract: A puncture free bottle cork has a body and a cap for covering a bottle opening. The body has at least one channel defined therein for receiving a syringe or an infusion bottle connector. The body is composed of an exterior body and a flange integrally formed with and extending downward from the exterior body for direct insertion of the bottle opening. The number of the at least one channel corresponds to number of the syringe or the infusion bottle connector such that when the number of the at least one channel is one, injection and drawing of medication to/from the bottle is using the single one channel and when the number of the at least one channel is plural, injection and drawing of medication to/from the bottle is using different channels.